Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 396947, 9 pages
http://dx.doi.org/10.1155/2014/396947
Research Article

Rho GTPase-Activating Protein 35 rs1052667 Polymorphism and Osteosarcoma Risk and Prognosis

Jinmin Zhao,1,2 Hua Xu,2,3 Maolin He,2,4 Zhe Wang,2,4 and Yang Wu2,4

1Department of Orthopaedics Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
2Research Center for Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
3Center for Education Evaluation & Faculty Development, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
4Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China

Received 5 February 2014; Revised 30 May 2014; Accepted 30 June 2014; Published 20 July 2014

Academic Editor: Urszula Demkow

Copyright © 2014 Jinmin Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Gorlick, K. Janeway, S. Lessnick, R. L. Randall, and N. Marina, “Children's oncology group's 2013 blueprint for research: bone tumors,” Pediatric Blood & Cancer, vol. 60, no. 6, pp. 1009–1015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Geller and R. Gorlick, “Osteosarcoma: a review of diagnosis, management, and treatment strategies,” Clinical Advances in Hematology and Oncology, vol. 8, no. 10, pp. 705–718, 2010. View at Google Scholar · View at Scopus
  3. Y. Cho, G. Jung, S. Chung, J. Kim, and Y. Choi, “Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution,” Clinics in Orthopedic Surgery, vol. 3, no. 1, pp. 48–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Lamoureux, V. Trichet, C. Chipoy, F. Blanchard, F. Gouin, and F. Redini, “Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies,” Expert Review of Anticancer Therapy, vol. 7, no. 2, pp. 169–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Chang, R. Song, S. Xu, M. Xu, and X. Yu, “CD 152 gene polymorphisms and risk of osteosarcoma in Chinese population,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  6. Z. Wang, P. Wen, X. Luo et al., “Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population,” Tumour Biology, vol. 35, no. 4, pp. 3605–3610, 2014. View at Google Scholar
  7. T. C. Hou, J. J. Lin, H. C. Wen, L. C. Chen, S. P. Hsu, and W. S. Lee, “Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP- signaling pathway,” Biochemical Pharmacology, vol. 85, no. 3, pp. 376–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Oinuma, K. Kawada, K. Tsukagoshi, and M. Negishi, “Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation,” Molecular Biology of the Cell, vol. 23, no. 8, pp. 1593–1604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Grinnell and E. O. Harrington, “Interplay between FAK, PKCδ, and p190RhoGAP in the regulation of endothelial barrier function,” Microvascular Research, vol. 83, no. 1, pp. 12–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Selva and G. Egea, “Ethanol increases p190RhoGAP activity, leading to actin cytoskeleton rearrangements,” Journal of Neurochemistry, vol. 119, no. 6, pp. 1306–1316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Németh, K. Futosi, C. Hably et al., “Neutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: Generation and analysis of a novel null mutation in mice,” Journal of Immunology, vol. 185, no. 5, pp. 3064–3075, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Naoe, K. Araki, O. Nagano et al., “The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation,” Molecular and Cellular Biology, vol. 30, no. 16, pp. 3994–4005, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. S. Manchinelly, J. A. Miller, L. Su et al., “Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis,” Journal of Biological Chemistry, vol. 285, no. 35, pp. 26923–26932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tomar, S. Lim, Y. Lim, and D. D. Schlaepfer, “A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells,” Journal of Cell Science, vol. 122, part 11, pp. 1852–1862, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. W. T. Arthur and K. Burridge, “RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity,” Molecular Biology of the Cell, vol. 12, no. 9, pp. 2711–2720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. G. A. Wildenberg, M. R. Dohn, R. H. Carnahan et al., “p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho,” Cell, vol. 127, no. 5, pp. 1027–1039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Mammoto, S. Huang, and D. E. Ingber, “Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts,” Journal of Cell Science, vol. 120, no. 3, pp. 456–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. K. Fordjour and E. O. Harrington, “PKCδ influences p190 phosphorylation and activity: events independent of PKCδ-mediated regulation of endothelial cell stress fiber and focal adhesion formation and barrier function,” Biochimica et Biophysica Acta—General Subjects, vol. 1790, no. 10, pp. 1179–1190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Shen, H. Chen, M. Lin et al., “Breast tumor kinase phosphorylates p190RhoGAP to regulate Rho and ras and promote breast carcinoma growth, migration, and invasion,” Cancer Research, vol. 68, no. 19, pp. 7779–7787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Wolf, N. Draghi, X. Liang et al., “p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human Chromosome 19q13.3,” Genes and Development, vol. 17, no. 4, pp. 476–487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tikoo, S. Czekay, C. Viars et al., “p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas,” Gene, vol. 257, no. 1, pp. 23–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Long, D. Zhao, C. Wang et al., “Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma,” Epidemiology, vol. 24, no. 5, pp. 671–681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Long, J. Yao, Z. Zeng et al., “Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma,” Hepatology, vol. 58, no. 1, pp. 171–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. C. Broders, “Squamous cell epithelioma of the skin: a study of 256 cases,” Annals of Surgery, vol. 73, no. 2, pp. 141–160, 1921. View at Google Scholar
  25. A. F. Mavrogenis, C. N. Abati, C. Romagnoli, and P. Ruggieri, “Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma,” Clinical Orthopaedics and Related Research, vol. 470, no. 6, pp. 1735–1748, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Tamura, M. Fukada, A. Fujikawa, and M. Noda, “Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP,” Neuroscience Letters, vol. 399, no. 1-2, pp. 33–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. W. T. Arthur, L. A. Petch, and K. Burridge, “Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism,” Current Biology, vol. 10, no. 12, pp. 719–722, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Ludwig and S. J. Parsons, “The tumor suppressor, p190RhoGAP, differentially initiates apoptosis and confers docetaxel sensitivity to breast cancer cells,” Genes and Cancer, vol. 2, no. 1, pp. 20–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Mignone, C. Gissi, S. Liuni, and G. Pesole, “Untranslated regions of mRNAs,” Genome Biology, vol. 3, no. 3, 2002. View at Google Scholar · View at Scopus
  30. H. Notsuda, A. Sakurada, C. Endo et al., “p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells,” International Journal of Oncology, vol. 43, no. 5, pp. 1569–1577, 2013. View at Publisher · View at Google Scholar
  31. I. Molina-Ortiz, R. A. Bartolomé, P. Hernández-Varas, G. P. Colo, and J. Teixidó, “Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA,” Journal of Biological Chemistry, vol. 284, no. 22, pp. 15147–15157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Chakravarty, D. Roy, M. Gonzales, J. Gay, A. Contreras, and J. M. Rosen, “p190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer,” Cell Growth and Differentiation, vol. 11, no. 7, pp. 343–354, 2000. View at Google Scholar · View at Scopus